Neurology Contract Research Organization Market by Geography : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research presents an in-depth analysis of the global Neurology Contract Research Organization (CRO) Market. This study provides a detailed examination of market trends, growth drivers, challenges, and emerging opportunities, delivering essential insights into the neurology CRO sector. It offers a comprehensive overview of the market, including crucial statistics and projections that outline the market's trajectory from 2024 to 2031.

Key Insights:

Market Size (2024): USD 8.4 Billion
Projected Market Value (2031): USD 13.2 Billion
Global Market Growth Rate (CAGR 2024 to 2031): 6.67%

Neurology Contract Research Organization Market - Report Scope:

The Neurology CRO Market facilitates crucial clinical research services for the pharmaceutical and biotechnology industries, focusing on neurological disorders such as Alzheimer's, Parkinson's, and multiple sclerosis. These organizations play a vital role in the development and implementation of neurology trials, offering services ranging from drug discovery and preclinical research to Phase I-IV trials and post-marketing surveillance.

Market Growth Drivers:

The market is driven by the increasing prevalence of neurological disorders globally, which heightens the demand for effective treatments. Neurology CROs are essential in navigating the complex regulatory environments and managing the intricate data involved in neurology trials. Advancements in neuroscience research methods and an increased focus on personalized medicine are further propelling market growth, providing opportunities for neurology CROs to expand their service offerings and improve trial efficiencies.

Market Restraints:

However, the Neurology CRO Market faces several challenges. High costs associated with neurology clinical trials and stringent regulatory requirements can pose significant barriers. Additionally, the complex nature of neurological diseases and the variability in patient responses can complicate trial designs and outcomes, impacting the speed and success of drug development processes.

Market Opportunities:

Emerging markets, advancements in neuroimaging and biomarker research, and the integration of artificial intelligence in clinical trials present lucrative opportunities for growth. These technologies enhance the precision and efficiency of clinical trials, enabling neurology CROs to deliver faster and more reliable results. There is also an increasing trend towards patient-centric trials, which offers a pathway for innovation in patient recruitment and retention strategies.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Neurology Contract Research Organization Market globally?
How are advancements in neuroscientific research methods shaping the future of neurology clinical trials?
What are the major challenges and opportunities for neurology CROs in the current market landscape?
Which neurological disorders are seeing the most significant investment in clinical trials?
What strategies are leading neurology CROs adopting to enhance their services and expand their market presence?

Competitive Intelligence and Business Strategy:

Leading players in the global Neurology CRO Market, including specialized neurology research organizations and full-service CROs, focus on leveraging technological advancements and enhancing operational efficiencies to maintain a competitive edge. These companies are investing in cutting-edge research techniques, robust data management systems, and strategic collaborations with pharmaceutical firms to optimize trial outcomes and accelerate drug development.

Key Companies Profiled:

Charles River Laboratories
Laboratory Corporation of America Holdings
IQVIA Inc.
Syneos Health
Parexel International Corporation
ICON Plc.
Medpace
Axon CRO

Neurology Contract Research Organization Market Segmentation

By Service:

Clinical Services
Early Phase/Phase I Development
Phase IIB-III Clinical Trials
Phase IIIB-Phase IV Clinical Trials
510(k) Clinical Studies
IDE Clinical Studies
IND Clinical Studies
PMA Clinical Studies
De Novo Clinical Studies
Retrospective Clinical Studies
Data Management Services
Clinical Database Selection
Clinical Study Planning and Clinical Protocol Development
Clinical Site Budget Development
Data Management (DM) and Biostatistics (BS)
Drug Safety
Medical and Scientific Writing
Regulatory Affairs
Pharmacology and Toxicology
Quality and Compliance

By Study:

Neuroscience focused
Neurology focused

By Indication:

Alzheimer's Disease
Brain Tumors
Epilepsy & Seizures
Headaches
Schizophrenia
Depressive Disorder
Multiple Sclerosis (MS)
Muscular Dystrophy
Parkinson's Disease
Progressive Muscular Atrophy (PMA)
Stroke
Psychiatry
Autism Spectrum Disorder
Cerebral Adrenoleukodystrophy (CALD)
Sleep Apnea/ Sleep Dysfunction

By End User:

Pharmaceutical & Biopharmaceutical Companies
Biopharmaceutical Companies
Medical Device Companies
Academic and Research Institutes

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Product Code: PMRREP33149

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Service Adoption
4.2. Key Strategies, by Market Players
4.3. PESTLE Analysis
4.4. Key Regulations
4.5. Sales Channel to End User Analysis
4.6. Insights on Commission of sales for CRO Contracts

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. GDP Growth Outlook
- 5.1.2. Healthcare Industry Market Outlook
- 5.1.3. R&D Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Companies' Historical Growth
- 5.2.2. New/Improved Solution Launches
- 5.2.3. Growing Number of CROs
- 5.2.4. Growing Research and Development Funding
- 5.2.5. Demand for Clinical Research
- 5.2.6. Increase in Research Activities in Neuroscience
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 Impact Analysis
- 6.1.1. By Service
- 6.1.2. By Study
- 6.1.3. By Indication
- 6.1.4. By End User
6.2. 2024 Market Scenario

7. Global Neurology Contract Research Organization Market (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031, by Service

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Service, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Service 2024-2031
- 8.3.1. Clinical Services
  - 8.3.1.1. Early Phase/Phase I Development
  - 8.3.1.2. Phase IIB-III Clinical Trials
  - 8.3.1.3. Phase IIIB-Phase IV Clinical Trials
  - 8.3.1.4. 510(k) Clinical Studies
  - 8.3.1.5. IDE Clinical Studies
  - 8.3.1.6. IND Clinical Studies
  - 8.3.1.7. PMA Clinical Studies
  - 8.3.1.8. De Novo Clinical Studies
  - 8.3.1.9. Retrospective Clinical Studies
- 8.3.2. Data Management Services
  - 8.3.2.1. Clinical Database Selection
  - 8.3.2.2. Clinical Study Planning and Clinical Protocol Development
  - 8.3.2.3. Clinical Site Budget Development
  - 8.3.2.4. Data Management (DM) and Biostatistics (BS)
- 8.3.3. Drug Safety
- 8.3.4. Medical and Scientific Writing
- 8.3.5. Regulatory Affairs
- 8.3.6. Pharmacology and Toxicology
- 8.3.7. Quality and Compliance
8.4. Market Attractiveness Analysis By Service

9. Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031, by Study

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Study, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Study, 2024-2031
- 9.3.1. Neuroscience focused
- 9.3.2. Neurology focused
9.4. Market Attractiveness Analysis By Study

10. Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2031
- 10.3.1. Alzheimer's Disease
- 10.3.2. Brain Tumors
- 10.3.3. Epilepsy & Seizures
- 10.3.4. Headaches
- 10.3.5. Schizophrenia
- 10.3.6. Depressive Disorder
- 10.3.7. Multiple Sclerosis (MS)
- 10.3.8. "Muscular Dystrophy
- 10.3.9. Parkinson's Disease
- 10.3.10. Progressive Muscular Atrophy (PMA)
- 10.3.11. Psychiatry
- 10.3.12. Autism Spectrum Disorder
- 10.3.13. Cerebral Adrenoleukodystrophy (CALD)
- 10.3.14. Sleep Apnea/ Sleep Dysfunction
10.4. Market Attractiveness Analysis By Indication

11. Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031, by End User

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
- 11.3.1. Pharmaceutical & Biopharmaceutical Companies
- 11.3.2. Biotechnology Companies
- 11.3.3. Medical Device Companies
- 11.3.4. Academic and Research Institutes
11.4. Market Attractiveness Analysis By End User

12. Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031, by Region

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. South Asia
- 12.3.5. East Asia
- 12.3.6. Oceania
- 12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region

13. North America Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 13.3.1. By Country
  - 13.3.1.1. U.S.
  - 13.3.1.2. Canada
- 13.3.2. By Service
- 13.3.3. By Study
- 13.3.4. By Indication
- 13.3.5. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Service
- 13.4.3. By Study
- 13.4.4. By Indication
- 13.4.5. By End User
13.5. Country Level Analysis & Forecast
- 13.5.1. U.S. Neurology Contract Research Organization Market
  - 13.5.1.1. .Introduction
  - 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.1.2.1. By Service
    - 13.5.1.2.2. By Study
    - 13.5.1.2.3. By Indication
    - 13.5.1.2.4. By End User
- 13.5.2. Canada Neurology Contract Research Organization Market
  - 13.5.2.1. Introduction
  - 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.2.2.1. By Service
    - 13.5.2.2.2. By Study
    - 13.5.2.2.3. By Indication
    - 13.5.2.2.4. By End User
13.6. Drivers and Restraints - Impact Analysis

14. Latin America Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 14.3.1. By Country
  - 14.3.1.1. Brazil
  - 14.3.1.2. Mexico
  - 14.3.1.3. Argentina
  - 14.3.1.4. Rest of Latin America
- 14.3.2. By Service
- 14.3.3. By Study
- 14.3.4. By Indication
- 14.3.5. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Service
- 14.4.3. By Study
- 14.4.4. By Indication
- 14.4.5. By End User
14.5. Country Level Analysis & Forecast
- 14.5.1. Brazil Neurology Contract Research Organization Market Analysis
  - 14.5.1.1. Introduction
  - 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.1.2.1. By Service
    - 14.5.1.2.2. By Study
    - 14.5.1.2.3. By Indication
    - 14.5.1.2.4. By End User
- 14.5.2. Mexico Neurology Contract Research Organization Market Analysis
  - 14.5.2.1. Introduction
  - 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.2.2.1. By Service
    - 14.5.2.2.2. By Study
    - 14.5.2.2.3. By Indication
    - 14.5.2.2.4. By End User
- 14.5.3. Argentina Neurology Contract Research Organization Market Analysis
  - 14.5.3.1. Introduction
  - 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.3.2.1. By Service
    - 14.5.3.2.2. By Study
    - 14.5.3.2.3. By Indication
    - 14.5.3.2.4. By End User
14.6. Drivers and Restraints - Impact Analysis

15. Europe Global Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 15.3.1. By Country
  - 15.3.1.1. U.K.
  - 15.3.1.2. Germany
  - 15.3.1.3. Italy
  - 15.3.1.4. France
  - 15.3.1.5. Spain
  - 15.3.1.6. Russia
  - 15.3.1.7. Nordic Countries
  - 15.3.1.8. BENELUX
  - 15.3.1.9. Rest of Europe
- 15.3.2. By Service
- 15.3.3. By Study
- 15.3.4. By Indication
- 15.3.5. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Service
- 15.4.3. By Study
- 15.4.4. By Indication
- 15.4.5. By End User
15.5. Country Level Analysis & Forecast
- 15.5.1. U.K. Global Neurology Contract Research Organization Market
  - 15.5.1.1. Introduction
  - 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.1.2.1. By Service
    - 15.5.1.2.2. By Study
    - 15.5.1.2.3. By Indication
    - 15.5.1.2.4. By End User
- 15.5.2. Germany Neurology Contract Research Organization Market
  - 15.5.2.1. .Introduction
  - 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.2.2.1. By Service
    - 15.5.2.2.2. By Study
    - 15.5.2.2.3. By Indication
    - 15.5.2.2.4. By End User
- 15.5.3. Italy Neurology Contract Research Organization Market
  - 15.5.3.1. Introduction
  - 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.3.2.1. By Service
    - 15.5.3.2.2. By Study
    - 15.5.3.2.3. By Indication
    - 15.5.3.2.4. By End User
- 15.5.4. France Neurology Contract Research Organization Market
  - 15.5.4.1. Introduction
  - 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.4.2.1. By Service
    - 15.5.4.2.2. By Study
    - 15.5.4.2.3. By Indication
    - 15.5.4.2.4. By End User
- 15.5.5. Spain Neurology Contract Research Organization Market
  - 15.5.5.1. Introduction
  - 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.5.2.1. By Service
    - 15.5.5.2.2. By Study
    - 15.5.5.2.3. By Indication
    - 15.5.5.2.4. By End User
- 15.5.6. Russia Neurology Contract Research Organization Market
  - 15.5.6.1. Introduction
  - 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.6.2.1. By Service
    - 15.5.6.2.2. By Study
    - 15.5.6.2.3. By Indication
    - 15.5.6.2.4. By End User
- 15.5.7. Nordic Countries Neurology Contract Research Organization Market
  - 15.5.7.1. Introduction
  - 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.7.2.1. By Service
    - 15.5.7.2.2. By Study
    - 15.5.7.2.3. By Indication
    - 15.5.7.2.4. By End User
- 15.5.8. BENELUX Neurology Contract Research Organization Market
  - 15.5.8.1. Introduction
  - 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.8.2.1. By Service
    - 15.5.8.2.2. By Study
    - 15.5.8.2.3. By Indication
    - 15.5.8.2.4. By End User
15.6. Drivers and Restraints - Impact Analysis

16. South Asia Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Thailand
  - 16.3.1.3. Indonesia
  - 16.3.1.4. Malaysia
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Service
- 16.3.3. By Study
- 16.3.4. By Indication
- 16.3.5. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Service
- 16.4.3. By Study
- 16.4.4. By Indication
- 16.4.5. By End User
16.5. Country Level Analysis & Forecast
- 16.5.1. India Neurology Contract Research Organization Market Analysis
  - 16.5.1.1. Introduction
  - 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.1.2.1. By Service
    - 16.5.1.2.2. By Study
    - 16.5.1.2.3. By Indication
    - 16.5.1.2.4. By End User
- 16.5.2. Thailand Neurology Contract Research Organization Market Analysis
  - 16.5.2.1. .Introduction
  - 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.2.2.1. By Service
    - 16.5.2.2.2. By Study
    - 16.5.2.2.3. By Indication
    - 16.5.2.2.4. By End User
- 16.5.3. Indonesia Neurology Contract Research Organization Market Analysis
  - 16.5.3.1. Introduction
  - 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.3.2.1. By Service
    - 16.5.3.2.2. By Study
    - 16.5.3.2.3. By Indication
    - 16.5.3.2.4. By End User
- 16.5.4. Malaysia Neurology Contract Research Organization Market Analysis
  - 16.5.4.1. Introduction
  - 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.4.2.1. By Service
    - 16.5.4.2.2. By Study
    - 16.5.4.2.3. By Indication
    - 16.5.4.2.4. By End User
16.6. Drivers and Restraints - Impact Analysis

17. East Asia Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Service
- 17.3.3. By Study
- 17.3.4. By Indication
- 17.3.5. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Service
- 17.4.3. By Study
- 17.4.4. By Indication
- 17.4.5. By End User
17.5. Country Level Analysis & Forecast
- 17.5.1. China Neurology Contract Research Organization Market Analysis
  - 17.5.1.1. Introduction
  - 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.1.2.1. By Service
    - 17.5.1.2.2. By Study
    - 17.5.1.2.3. By Indication
    - 17.5.1.2.4. By End User
- 17.5.2. Japan Neurology Contract Research Organization Market Analysis
  - 17.5.2.1. Introduction
  - 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.2.2.1. By Service
    - 17.5.2.2.2. By Study
    - 17.5.2.2.3. By Indication
    - 17.5.2.2.4. By End User
- 17.5.3. South Korea Neurology Contract Research Organization Market Analysis
  - 17.5.3.1. Introduction
  - 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.3.2.1. By Service
    - 17.5.3.2.2. By Study
    - 17.5.3.2.3. By Indication
    - 17.5.3.2.4. By End User
17.6. Drivers and Restraints - Impact Analysis

18. Oceania Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 18.3.1. By Country
  - 18.3.1.1. Australia
  - 18.3.1.2. New Zealand
- 18.3.2. By Service
- 18.3.3. By Study
- 18.3.4. By Indication
- 18.3.5. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Service
- 18.4.3. By Study
- 18.4.4. By Indication
- 18.4.5. By End User
18.5. Country Level Analysis & Forecast
- 18.5.1. Australia Neurology Contract Research Organization Market Analysis
  - 18.5.1.1. Introduction
  - 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.5.1.2.1. By Service
    - 18.5.1.2.2. By Study
    - 18.5.1.2.3. By Indication
    - 18.5.1.2.4. By End User
- 18.5.2. New Zealand Neurology Contract Research Organization Market Analysis
  - 18.5.2.1. Introduction
  - 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.5.2.2.1. By Service
    - 18.5.2.2.2. By Study
    - 18.5.2.2.3. By Indication
    - 18.5.2.2.4. By End User
18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Neurology Contract Research Organization Market Analysis 2019-2023 and Forecast 2024-2031

19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 19.3.1. By Country
  - 19.3.1.1. GCC Countries
  - 19.3.1.2. Turkey
  - 19.3.1.3. North Africa
  - 19.3.1.4. South Africa
  - 19.3.1.5. Rest of Middle East and Africa
- 19.3.2. By Service
- 19.3.3. By Study
- 19.3.4. By Indication
- 19.3.5. By End User
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Service
- 19.4.3. By Study
- 19.4.4. By Indication
- 19.4.5. By End User
19.5. Country Level Analysis & Forecast
- 19.5.1. GCC Countries Neurology Contract Research Organization Market Analysis
  - 19.5.1.1. Introduction
  - 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.5.1.2.1. By Service
    - 19.5.1.2.2. By Study
    - 19.5.1.2.3. By Indication
    - 19.5.1.2.4. By End User
- 19.5.2. Turkey Neurology Contract Research Organization Market Analysis
  - 19.5.2.1. Introduction
  - 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.5.2.2.1. By Service
    - 19.5.2.2.2. By Study
    - 19.5.2.2.3. By Indication
    - 19.5.2.2.4. By End User
- 19.5.3. North Africa Neurology Contract Research Organization Market Analysis
  - 19.5.3.1. Introduction
  - 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 19.5.3.2.1. By Service
    - 19.5.3.2.2. By Study
    - 19.5.3.2.3. By Indication
    - 19.5.3.2.4. By End User
- 19.5.4. South Africa Neurology Contract Research Organization Market Analysis
  - 19.5.4.1. Introduction
  - 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 19.5.4.2.1. By Service
    - 19.5.4.2.2. By Study
    - 19.5.4.2.3. By Indication
    - 19.5.4.2.4. By End User
19.6. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis (%) of Top Players
20.3. Market Presence Analysis

21. Competition Analysis

21.1. Competition Dashboard
21.2. Competition Deep Dive
- 21.2.1. Charles River Laboratories
  - 21.2.1.1. Overview
  - 21.2.1.2. Product Portfolio
  - 21.2.1.3. Key Financials
  - 21.2.1.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.1.5. Sales Footprint
  - 21.2.1.6. SWOT Analysis
  - 21.2.1.7. Strategy Overview
- 21.2.2. Laboratory Corporation of America Holdings
  - 21.2.2.1. Overview
  - 21.2.2.2. Product Portfolio
  - 21.2.2.3. Key Financials
  - 21.2.2.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.2.5. Sales Footprint
  - 21.2.2.6. SWOT Analysis
  - 21.2.2.7. Strategy Overview
- 21.2.3. IQVIA Inc.
  - 21.2.3.1. Overview
  - 21.2.3.2. Product Portfolio
  - 21.2.3.3. Key Financials
  - 21.2.3.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.3.5. Sales Footprint
  - 21.2.3.6. SWOT Analysis
  - 21.2.3.7. Strategy Overview
- 21.2.4. Parexel International Corporation
  - 21.2.4.1. Overview
  - 21.2.4.2. Product Portfolio
  - 21.2.4.3. Key Financials
  - 21.2.4.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.4.5. Sales Footprint
  - 21.2.4.6. SWOT Analysis
  - 21.2.4.7. Strategy Overview
- 21.2.5. ICON plc.
  - 21.2.5.1. Overview
  - 21.2.5.2. Product Portfolio
  - 21.2.5.3. Key Financials
  - 21.2.5.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.5.5. Sales Footprint
  - 21.2.5.6. SWOT Analysis
  - 21.2.5.7. Strategy Overview
- 21.2.6. Medpace
  - 21.2.6.1. Overview
  - 21.2.6.2. Product Portfolio
  - 21.2.6.3. Key Financials
  - 21.2.6.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.6.5. Sales Footprint
  - 21.2.6.6. SWOT Analysis
  - 21.2.6.7. Strategy Overview
- 21.2.7. Syneos Health
  - 21.2.7.1. Overview
  - 21.2.7.2. Product Portfolio
  - 21.2.7.3. Key Financials
  - 21.2.7.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.7.5. Sales Footprint
  - 21.2.7.6. SWOT Analysis
  - 21.2.7.7. Strategy Overview
- 21.2.8. Thermo Fisher Scientific (PPD Inc.)
  - 21.2.8.1. Overview
  - 21.2.8.2. Product Portfolio
  - 21.2.8.3. Key Financials
  - 21.2.8.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.8.5. Sales Footprint
  - 21.2.8.6. SWOT Analysis
  - 21.2.8.7. Strategy Overview
- 21.2.9. Pharmaron Beijing Co., Ltd.
  - 21.2.9.1. Overview
  - 21.2.9.2. Product Portfolio
  - 21.2.9.3. Key Financials
  - 21.2.9.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.9.5. Sales Footprint
  - 21.2.9.6. SWOT Analysis
  - 21.2.9.7. Strategy Overview
- 21.2.10. Neuroservices Alliance
  - 21.2.10.1. Overview
  - 21.2.10.2. Product Portfolio
  - 21.2.10.3. Key Financials
  - 21.2.10.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.10.5. Sales Footprint
  - 21.2.10.6. SWOT Analysis
  - 21.2.10.7. Strategy Overview
- 21.2.11. QPS Neuropharmacology
  - 21.2.11.1. Overview
  - 21.2.11.2. Product Portfolio
  - 21.2.11.3. Key Financials
  - 21.2.11.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.11.5. Sales Footprint
  - 21.2.11.6. SWOT Analysis
  - 21.2.11.7. Strategy Overview
- 21.2.12. MD Biosciences
  - 21.2.12.1. Overview
  - 21.2.12.2. Product Portfolio
  - 21.2.12.3. Key Financials
  - 21.2.12.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.12.5. Sales Footprint
  - 21.2.12.6. SWOT Analysis
  - 21.2.12.7. Strategy Overview
- 21.2.13. CTI Clinical Trial and Consulting Services
  - 21.2.13.1. Overview
  - 21.2.13.2. Product Portfolio
  - 21.2.13.3. Key Financials
  - 21.2.13.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.13.5. Sales Footprint
  - 21.2.13.6. SWOT Analysis
  - 21.2.13.7. Strategy Overview
- 21.2.14. Atlantic Research Group, Inc.
  - 21.2.14.1. Overview
  - 21.2.14.2. Product Portfolio
  - 21.2.14.3. Key Financials
  - 21.2.14.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.14.5. Sales Footprint
  - 21.2.14.6. SWOT Analysis
  - 21.2.14.7. Strategy Overview
- 21.2.15. EphyX Neuroscience
  - 21.2.15.1. Overview
  - 21.2.15.2. Product Portfolio
  - 21.2.15.3. Key Financials
  - 21.2.15.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.15.5. Sales Footprint
  - 21.2.15.6. SWOT Analysis
  - 21.2.15.7. Strategy Overview
- 21.2.16. Ergomed PLC
  - 21.2.16.1. Overview
  - 21.2.16.2. Product Portfolio
  - 21.2.16.3. Key Financials
  - 21.2.16.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.16.5. Sales Footprint
  - 21.2.16.6. SWOT Analysis
  - 21.2.16.7. Strategy Overview
- 21.2.17. Neuron Experts
  - 21.2.17.1. Overview
  - 21.2.17.2. Product Portfolio
  - 21.2.17.3. Key Financials
  - 21.2.17.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.17.5. Sales Footprint
  - 21.2.17.6. SWOT Analysis
  - 21.2.17.7. Strategy Overview
- 21.2.18. Axon CRO
  - 21.2.18.1. Overview
  - 21.2.18.2. Product Portfolio
  - 21.2.18.3. Key Financials
  - 21.2.18.4. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.18.5. Sales Footprint
  - 21.2.18.6. SWOT Analysis
  - 21.2.18.7. Strategy Overview